Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study

    March 2019 in “ Drugs - Real World Outcomes ”
    Yukinori Sakata, Toshifumi Matsuoka, Satoshi Ohashi, Tadashi Koga, Tetsumi Toyoda, Mika Ishii
    Image of study
    TLDR Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.
    The study analyzed data from 551 patients in a healthcare claims database (DB) and 951 patients in a prospective post-marketing surveillance (PMS) to compare the safety profiles of eribulin mesylate, a breast cancer treatment, in Japan. While patient characteristics and drug use were generally similar between the two groups, there were significant differences in the reported incidence of adverse events (AEs), such as nausea, neutropenia, stomatitis, and alopecia. The study also noted a trend of increasing eribulin administrations and decreasing concomitant hormone therapy use over time, as well as a significant decrease in the incidence of anemia and pyrexia from 2011 to 2016. The findings suggest that healthcare claims databases can complement PMS in pharmacovigilance, despite potential under- or over-reporting of some AEs in the DB. The study was funded by Eisai Co. Ltd., with authors affiliated with the company and Clinical Study Support, Inc.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community How true is the statement: dead follicles don't grow back?

      in Research/Science  107 upvotes 6 months ago
      Hair follicles usually go dormant rather than die, and treatments like finasteride, minoxidil, and hormone therapy can sometimes reactivate them, though results vary. Complete regrowth is rare, especially in long-term bald areas, but some individuals see significant improvement with these treatments.

      community What is the ultimate hair regrowth protocol

      in Treatment  28 upvotes 1 month ago
      The conversation covers aggressive hair regrowth treatments like Dutasteride, Minoxidil (oral and topical), RU58841, microneedling, and ketoconazole shampoo. It also mentions PRP, laser therapy, GHK-Cu injections, and hormone therapy for maximum regrowth.

      community Oral Dut/Minoxidil for two years - no results.

      in Treatment  102 upvotes 1 week ago
      The user has used oral Dutasteride and Minoxidil for two years without regrowth, despite trying Finasteride and supplements. They consider increasing Minoxidil, adding microneedling, and switching medications, while others suggest RU58841, a hair transplant, or checking for other hair loss causes.

    Similar Research

    6 / 1000+ results